Fusion Pharm Stock

Fusion Pharm Current Liabilities

The Current Liabilities of Fusion Pharm (FSPM) as of Aug 24, 2026 is 174,400.00 USD. In the previous year, Current Liabilities was 66,900.00 USD — a change of 160.69% (higher).

Current Liabilities

174,400.00USD

YoY

160.69%

Last updated:

Current Liabilities of Fusion Pharm is 2026 174,400.00 USD. Current Liabilities of Fusion Pharm was 2025 66,900.00 USD. It decreases by 160.69% higher compared to the previous year.

The Fusion Pharm Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 1995
3.06 M USD
Jan 1, 1996
846,000.00 USD
Jan 1, 1997
581,000.00 USD
Jan 1, 2011
66,900.00 USD
Jan 1, 2012
174,400.00 USD
The Fusion Pharm Current Liabilities history
YEARCurrent LiabilitiesYoY
174,400.00USD+160.69%
66,900.00USD-88.49%
581,000.00USD-31.32%
846,000.00USD-72.39%
3.06 MUSD
Access this data via the Eulerpool API

Fusion Pharm Stock analysis

What does Fusion Pharm do? Fusion Pharm Inc is a well-known company in the agricultural industry that operates in various business sectors. It was founded in 2010 by Scott Dittman with the idea of improving agricultural efficiency through the use of innovative technologies. Fusion Pharm has gradually built different business areas focused on the development and marketing of products for optimizing agriculture. One of Fusion Pharm's core areas is the production of modular cultivation systems for plants that utilize cutting-edge technologies. These systems, called "PharmaCubes," are designed to provide optimal conditions for plants and achieve higher crop yields. They are particularly intended for use in urban spaces and other environments where traditional cultivation methods may not be feasible. The advantage of these systems lies in their scalability, and they are optimized for indoor use. Another important business area for Fusion Pharm is the production of fertilizers and other agricultural chemicals. These products are marketed under the brand name "Agritabs" and are aimed at promoting healthier plant growth and higher crop yields. The agricultural chemicals are made from natural raw materials, making them more environmentally friendly than many other products on the market. They are intended for use in various industries, including agriculture, gardening and landscaping, and the food industry. In addition to manufacturing and supplying cultivation systems, Fusion Pharm also operates in the production and distribution of natural fertilizers and other agricultural chemicals. The company has also undertaken a pilot project for closed-room fish farming and established itself in the aquaculture industry. In recent years, the company has pursued an aggressive acquisition strategy to expand into new business fields. One of these acquisitions was the takeover of the cloud-based software company "CannaCube," which has developed a management system for cannabis cultivation. Through the acquisition of CannaCube, Fusion Pharm has now positioned its portfolio for the growing cannabis industry. The company has made a name for itself in the agricultural industry by optimizing existing processes for sustainable and efficient plant development. With its innovative technology and products, the company contributes to greater efficiency and a more environmentally friendly agricultural industry. Fusion Pharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fusion Pharm stock

Current Liabilities of Fusion Pharm is 174,400.00 USD in 2026.

Current Liabilities of Fusion Pharm changed from 66,900.00 USD to 174,400.00 USD, representing a 160.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Fusion Pharm since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Fusion Pharm historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Fusion Pharm

All Key Metrics — Fusion Pharm